東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Development of Controlled Release Sy...

Wang, Yuchen.

FindBook

Google Book

Amazon

博客來

Development of Controlled Release Systems for Fracture-Targeted Therapeutic Delivery.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Development of Controlled Release Systems for Fracture-Targeted Therapeutic Delivery./
作者:	Wang, Yuchen.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
面頁冊數:	273 p.
附註:	Source: Dissertations Abstracts International, Volume: 79-10, Section: B.
Contained By:	Dissertations Abstracts International79-10B.
標題:	Biomedical engineering. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10745594
ISBN:	9780355791242

Development of Controlled Release Systems for Fracture-Targeted Therapeutic Delivery.
Wang, Yuchen.

Development of Controlled Release Systems for Fracture-Targeted Therapeutic Delivery. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 273 p.

Source: Dissertations Abstracts International, Volume: 79-10, Section: B.

Thesis (Ph.D.)--University of Rochester, 2018.

This item is not available from ProQuest Dissertations & Theses.

Fracture healing is a major clinical challenge, with a 10-20% impaired healing rate, resulting in significantly prolonged hospitalization, decreased quality of life, and substantial healthcare costs. Currently, myriad therapeutics that target various mechanisms and signaling pathways have been developed to augment fracture healing. Apart from bone morphogenic protein (BMP) implants, there are currently no FDA approved fracture healing enhancement drugs on the market. A major challenge of the bench side to bedside translation is efficient drug delivery. This motivates the goal of this dissertation, which is to develop successful drug delivery systems that can overcome critical barriers to realize clinical translation. Drug delivery barriers to bone fracture enhancement therapies include short half-life in vivo, non-specific accumulation in healthy tissue, as well as associated side effects. The studies herein provide strategies for local and systemic drug delivery. Specifically, the local delivery system in this thesis consists of polymer-based hydrogels loaded with siRNA/nanoparticle (NP) complexes. The local drug delivery system takes advantages of the NP's ability to protect siRNA and facilitate cell uptake, and the hydrogel's ability to localize and sustain the encapsulated content at the fracture site. Results showed controlled release of siRNA/NPs complexes from hydrogels through hydrolytic degradation. Localization of NPs at fracture was associated with degradation rates of hydrogels such that hydrogels with the slowest degradation rates yielded longer localization at fracture. Hydrogels that delivered siNRA/NP for ~ 1 month were implanted in a murine fracture model, and in vivo gene silencing efficiency indicated potent and expedited healing. In the systemic drug delivery system, polymeric NPs with bone-targeting peptides conjugated onto the NP corona were used to realize bone targeting efficacy. Potent fracture-targeting efficiency was observed, and NPs accumulated at fractures for ~ 7 days. NPs loaded with a small molecule GSK-3β inhibitor and showed fracture site-specific β-catenin agonism, enhanced bone mechanical properties, and faster healing rates. Taken together, the two drug delivery strategies explored here establish solid platforms for design of next generation drug delivery systems to fracture.

ISBN: 9780355791242Subjects--Topical Terms:

535387
Biomedical engineering.
Subjects--Index Terms:

Fracture healing

Development of Controlled Release Systems for Fracture-Targeted Therapeutic Delivery.
LDR:03615nmm a2200349 4500 001 2267569
005 20200724103001.5
008 220629s2018 ||||||||||||||||| ||eng d
020 $a 9780355791242
035 $a (MiAaPQ)AAI10745594
035 $a (MiAaPQ)rochester:11593
035 $a AAI10745594
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wang, Yuchen. $3 3412161
245 1 0 $a Development of Controlled Release Systems for Fracture-Targeted Therapeutic Delivery.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 273 p.
500 $a Source: Dissertations Abstracts International, Volume: 79-10, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Benoit, Danielle S. W.
502 $a Thesis (Ph.D.)--University of Rochester, 2018.
506 $a This item is not available from ProQuest Dissertations & Theses.
506 $a This item must not be added to any third party search indexes.
506 $a This item must not be sold to any third party vendors.
520 $a Fracture healing is a major clinical challenge, with a 10-20% impaired healing rate, resulting in significantly prolonged hospitalization, decreased quality of life, and substantial healthcare costs. Currently, myriad therapeutics that target various mechanisms and signaling pathways have been developed to augment fracture healing. Apart from bone morphogenic protein (BMP) implants, there are currently no FDA approved fracture healing enhancement drugs on the market. A major challenge of the bench side to bedside translation is efficient drug delivery. This motivates the goal of this dissertation, which is to develop successful drug delivery systems that can overcome critical barriers to realize clinical translation. Drug delivery barriers to bone fracture enhancement therapies include short half-life in vivo, non-specific accumulation in healthy tissue, as well as associated side effects. The studies herein provide strategies for local and systemic drug delivery. Specifically, the local delivery system in this thesis consists of polymer-based hydrogels loaded with siRNA/nanoparticle (NP) complexes. The local drug delivery system takes advantages of the NP's ability to protect siRNA and facilitate cell uptake, and the hydrogel's ability to localize and sustain the encapsulated content at the fracture site. Results showed controlled release of siRNA/NPs complexes from hydrogels through hydrolytic degradation. Localization of NPs at fracture was associated with degradation rates of hydrogels such that hydrogels with the slowest degradation rates yielded longer localization at fracture. Hydrogels that delivered siNRA/NP for ~ 1 month were implanted in a murine fracture model, and in vivo gene silencing efficiency indicated potent and expedited healing. In the systemic drug delivery system, polymeric NPs with bone-targeting peptides conjugated onto the NP corona were used to realize bone targeting efficacy. Potent fracture-targeting efficiency was observed, and NPs accumulated at fractures for ~ 7 days. NPs loaded with a small molecule GSK-3β inhibitor and showed fracture site-specific β-catenin agonism, enhanced bone mechanical properties, and faster healing rates. Taken together, the two drug delivery strategies explored here establish solid platforms for design of next generation drug delivery systems to fracture.
590 $a School code: 0188.
650 4 $a Biomedical engineering. $3 535387
653 $a Fracture healing
690 $a 0541
710 2 $a University of Rochester. $b Hajim School of Engineering and Applied Sciences. $3 2099687
773 0 $t Dissertations Abstracts International $g 79-10B.
790 $a 0188
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10745594